4Weimar C,Mieck T,Buchthal J,et al.Neurologic worsen-ing during the acute phase of ischemic stroke[J].Arch Neu-rol,2005,62(3):393.
5Johnson D J,Li W,Adams T E,et al.Antithrombin-S195Afactor Xa-heparin structure reveals the allosteric mechanism ofantithrombin activation[J].EMBO J,2006,25(9):2029.
6Griffin J H,Fernández J A,Liu D,et al.Activated proteinC and ischemic stroke[J].Crit Care Med,2004,32(5 Sup-pl):S247.
7Mallolas J,Hurtado O,Castellanos M,et al.A polymor-phism in the EAAT2 promoter is associated with higher glu-tamate concentrations and higher frequency of progressingstroke[J].Exp Med,2006,203(3):711.
8Shibata M,Kumar S R,Amar A,et al.Ant-iinflammatory,antithrombotic,and neuroprotective effects of activated pro-tein C in a murine model of focal ischemic stroke[J].Circula-tion,2001,103(13):1799.
9Ilhan D,Ozbabalik D,Gulcan E,et al.Evaluation of plateletactivation,coagulation,and fibrinolytic activation in patientswith symptomatic lacunar stroke[J].Neurologist,2010,16(3):188.
10Vuckovic B A,Djeric M J,Ilic T A,et al.Fibrinolytic pa-rameters,lipid status and lipoprotein(a)in ischemic strokepatients[J].Srp Arh Celok Lek,2010,138(Suppl 1):12.
